牛牛AI助理已提取核心訊息
Eli Lilly and Co officer, Zakrowski Donald A, is set to sell 750 shares of the company's common stock on 03/11/2024, with an aggregate market value of $565,200. The shares were originally acquired on 02/10/2023 as part of a performance share unit award under the issuer's equity compensation plan. This transaction follows a period where no securities were sold by Zakrowski in the past three months, as per the latest filings.
Eli Lilly and Co officer, Zakrowski Donald A, is set to sell 750 shares of the company's common stock on 03/11/2024, with an aggregate market value of $565,200. The shares were originally acquired on 02/10/2023 as part of a performance share unit award under the issuer's equity compensation plan. This transaction follows a period where no securities were sold by Zakrowski in the past three months, as per the latest filings.
禮來公司高管扎克羅夫斯基·唐納德·A定於2024年3月11日出售該公司750股普通股，總市值爲565,200美元。這些股票最初是在2023年10月2日作爲發行人股權薪酬計劃下的績效股份單位獎勵的一部分收購的。根據最新文件，該交易是在扎克羅夫斯基在過去三個月中沒有出售任何證券的時期之後進行的。
禮來公司高管扎克羅夫斯基·唐納德·A定於2024年3月11日出售該公司750股普通股，總市值爲565,200美元。這些股票最初是在2023年10月2日作爲發行人股權薪酬計劃下的績效股份單位獎勵的一部分收購的。根據最新文件，該交易是在扎克羅夫斯基在過去三個月中沒有出售任何證券的時期之後進行的。
有用
沒用